Huntington's disease

UniQure revs up engines again for Huntington's gene therapy after trial hospitalizations
Fierce Biotech
Wed, 11/2/22 - 10:49 pm
uniQure
Huntington's disease
gene therapy
AMT-130
Teva reports data from Huntington’s disease-linked chorea trial
Clinical Trials Arena
Wed, 10/19/22 - 10:54 am
Teva Pharmaceutical
Austedo
clinical trials
chorea
Huntington's disease
NeuBase Abandons Huntington's, 60% of Workforce in Strategic Pivot
BioSpace
Mon, 10/17/22 - 10:37 am
NeuBase
Huntington's disease
layoffs
Atlas-backed biotech focused on Huntington's disease shuts down less than three years after launch
Endpoints
Wed, 10/12/22 - 10:43 am
Triplet Therapeutics
Huntington's disease
Safety worries spur Novartis to suspend drug dosing in Huntington’s trial
BioPharma Dive
Thu, 08/25/22 - 11:29 am
Novartis
Huntington's disease
clinical trials
branaplam
BrainVectis gains approval for Phase I/II Huntington’s gene therapy trial
Clinical Trials Arena
Wed, 08/24/22 - 10:46 pm
AskBio
BrainVectis
clinical trials
Huntington's disease
uniQure pauses part of Huntington's trial after 3 patients hospitalized—1 of whom hasn’t fully recovered
Fierce Biotech
Mon, 08/8/22 - 11:33 pm
uniQure
clinical trials
Huntington's disease
AMT-130
uniQure shares spike as investors see bright spot in 12-month Huntington's gene therapy data
Fierce Biotech
Thu, 06/23/22 - 07:51 pm
uniQure
Huntington's disease
gene therapy
AMT-130
bit.bio’s New Huntington’s Disease Human Cell Model Set to Accelerate Drug Discovery and Screening
BioSpace
Mon, 05/9/22 - 11:26 pm
bit.bio
Huntington's disease
ioDisease Model
drug discovery
Roche sees cause for optimism with failed Huntington's disease drug. Others aren't so sure.
BioPharma Dive
Sat, 01/22/22 - 02:18 pm
Roche
clinical trials
Huntington's disease
Rewind: Roche returns to phase 2 after seeing post hoc signal in failed pivotal Huntington's trial
Fierce Biotech
Tue, 01/18/22 - 10:30 am
Roche
Ionis Pharmaceuticals
tominersen
Huntington's disease
clinical trials
Annexon becomes the latest group to provide a confusing update in Huntington's disease
EP Vantage
Wed, 01/5/22 - 10:45 am
Annexon Biosciences
Huntington's disease
clinical trials
ANX005
A high-profile gene therapy biotech takes aim at Huntington's
BioPharma Dive
Wed, 12/8/21 - 11:37 pm
Passage Bio
gene therapy
Huntington's disease
Origami Therapeutics developing treatments for neurodegenerative diseases with ML and computational chemistry
MedCity News
Thu, 11/4/21 - 10:26 am
Origami Therapeutics
protein degradation
neurodegenerative disease
Huntington's disease
Roche, hoping to move on from recent failure, pens $190M NeuExcell Huntington's disease pact
Fierce Biotech
Tue, 09/7/21 - 10:55 am
Roche
Huntington's disease
NeuExcell
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
clinical trials
Merck
Ridgeback Biotherapeutics
COVID-19
Intellia Therapeutics
transthyretin amyloidosis
Arcus Biosciences
Gilead Sciences
lung cancer
Sanofi
GSK
vaccines
uniQure
Huntington's disease
Mirati Therapeutics
gene editing
Seres Therapeutics
ulcerative colitis
Sarepta Therapeutics
Duchenne Muscular Dystrophy
UniQure moves Huntington's gene therapy to next phase of key trial
BioPharma Dive
Thu, 05/27/21 - 11:54 pm
uniQure
Huntington's disease
clinical trials
gene therapy
AMT-130
What caused Roche's Huntington's drug tominersen to hit the skids in late-stage test? It's complicated, analysts say
Endpoints
Wed, 04/28/21 - 10:22 am
Roche
Huntington's disease
tominersen
FDA says Voyager can trek on as it removes trial hold for Huntington's gene therapy test
Fierce Biotech
Mon, 04/26/21 - 11:15 am
FDA
Voyager Therapeutics
VY-HTT01
gene therapy
Huntington's disease
Prilenia hopes to buck the Huntington’s trend
EP Vantage
Thu, 04/1/21 - 10:45 am
Prilenia Therapeutics
Huntington's disease
Huntexil

Pages